Teprotumumab for Thyroid-Associated Ophthalmopathy

BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns. Inhibition of the insulin-like growth factor I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Smith, Terry J., Kahaly, George J., Ezra, Daniel G., Fleming, James C., Dailey, Roger A., Tang, Rosa A., Harris, Gerald J., Antonelli, Alessandro, Salvi, Mario, Goldberg, Robert A., Gigantelli, James W., Couch, Steven M., Shriver, Erin M., Hayek, Brent R., Hink, Eric M., Woodward, Richard M., Gabriel, Kathleen, Magni, Guido, Douglas, Raymond S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718164/
https://ncbi.nlm.nih.gov/pubmed/28467880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1614949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados